🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Want to ⬇️ risk of major HF events in your patients with HFrEF, with clinical benefits evident within the next 14 days? Michelle Kittleson MD PhD Muthu Vaduganathan Steve Greene Javed Butler Clyde Yancy, MD, MSc HFSA

The ISHLT/American Society of Transplantation (AST) Joint Statement on SARS-CoV-2 Vaccination in SOT Recipients now has the support of 24 total societies and organizations in transplantation. If you haven't read it yet, visit bit.ly/3joo79Z to download it.

Development and validation of specific post-transplant risk scores according to the circulatory support status at transplant: A UNOS cohort analysis dlvr.it/S40j5X

Kiran Khush The ISHLT ISHLT President Yes! Loved the chance to really meet these transplant leaders, some of whom I only knew via Zoom before now! Lara Danziger-Isakov Ulrich Jorde Jignesh Patel @ChristianBenden

Spread the word: mathew.maurer Ronald Witteles Mazen Hanna Frederick L Ruberg Brett Sperry, MD Vincent Rajkumar Michelle Kittleson MD PhD David Fermin, MD Omar AbouEzzeddine MDCM, MS (He/Him/His) Melissa Lyle Julie Lorraine Rosenthal Mayo Amyloid Vaishali Sanchorawala Ahmad Masri Michael Chetrit Dr. Jeffrey Zonder

#ISHLT2022 Great to see the fruits of a really fun labour! #Delphi panel figuring out how to manage tricky transplant infectious disease issues! Emily Blumberg Lara Danziger-Isakov Melinh Luong shahid.husain@tid Saima Aslam Jignesh Patel

My proudest moment of the year! #ISHLT 2022 was truly a family affair with both my sons Krishan Patel Nikhil Patel presenting alongside Jignesh Patel. Nice job guys!

Check out our new Circulation paper on Prediction algorithm to Minimize Surveillance Endomyocardial Biopsies After #Heart🫀Transplantation. Amazing collaboration Paris Transplant Group 🇫🇷 Cedars-Sinai 🇺🇸 Kudos to our colleagues & friends Jignesh Patel #JKobashigawa ahajournals.org/doi/10.1161/CI…

Honored to participate in the #INSHLT meeting in Hyderabad. Learning so much about the unique challenges faced by thoracic transplantation in India ⁦The ISHLT⁩ ⁦sandeep attawar⁩ ⁦Are Martin Holm⁩

Congrats to #INSHLT for providing education and improving awareness of HT in India. Donor heart use in Karnataka is only 15% due to lack of listed candidates, despite millions of patients with advanced HF in India! Great potential, with many unique obstacles ⁦The ISHLT⁩

A huge congratulations to Jon Kobashigawa, recipient of the 2023 ISHLT Lifetime Achievement Award! Nobody more deserving. youtu.be/kshFkKCixeA The ISHLT Jignesh Patel Lara Danziger-Isakov Jeff Teuteberg #ishlt2023

Jon Kobashigawa receives the Lifetime Achievement Award at #ISHLT2023. He is a true pioneer and legend in the field, paving the way for the heart transplant field for what it is today. His research and dedication inspires us all. Michelle Kittleson MD PhD Jignesh Patel The ISHLT

Yoni Nattiv The ISHLT Cedars-Sinai Michelle Kittleson MD PhD Jignesh Patel Congratulations to a one-in-a-million mentor. Your career and humility gives us all something to aspire to.

Great job by Amey Vrudhula in presenting his work on AI screening for cardiac amyloidosis at Sarnoff Foundation annual meeting. His preprint is here: medrxiv.org/content/10.110…

Jignesh Patel Guillaume Bonnet

Grateful to be a part of the Cardiac Amyloidosis Registry Study (CARS): largest multicenter registry of diverse #CardiacAmyloid pts (both AL & ATTR) in US. Read the Rationale/design paper headlined by Lily K Stern MD Jignesh Patel Michelle Kittleson MD PhD et al 👉 sciencedirect.com/science/articl…

Stellar Smidt Heart Institute at Cedars-Sinai #research seminar by Peter Heeger, ace clinical #immunologist Cedars-Sinai Academic Medicine. How to improve #transplant graft function? One promising approach is C1 inhibition, already in clinical trials.

1. DPP3 = enzyme involved in angiotensin II & enkephalin cleavage ✂️ High levels are associated with cardiogenic shock, and early reductions are associated with favorable outcomes. Procizumab is a monoclonal antibody against DPP3 that is heading into clinical trials in Europe 🇪🇺

2. Transcatheter ventriculoplasty (i.e. via AccuCinch, MIRTH, Carillon) - early data suggests a global ventricular remodeling process (mediated neurohormonally?) can occur after a local physical cinching of the LV in HFrEF pts on optimal GDMT (below: AccuCinch from Journal of Cardiac Failure)

3. Innovation demands courage from physicians + bravery from patients. Mark Drazner emphasized the importance of finding meaning in work. As I shape my future career, being part of innovation for HF pts in dire need of better care sounds like a great way to ⬆️ meaning in my work